We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$26.1B
AUM Growth
+$1.03B
(+4.1%)
Cap. Flow
-$146M
Cap. Flow
% of AUM
-0.56%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
1,470
New
112
Increased
493
Reduced
531
Closed
130
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$94.2M |
| 2 |
Medtronic
MDT
|
+$83.5M |
| 3 |
Verizon
VZ
|
+$54.1M |
| 4 |
Adobe
ADBE
|
+$54.1M |
| 5 |
Amazon
AMZN
|
+$50.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$81.3M |
| 2 |
Sensata Technologies
ST
|
+$78M |
| 3 |
PG&E
PCG
|
+$52M |
| 4 |
Amgen
AMGN
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Healthcare | 15.83% |
| 3 | Consumer Discretionary | 11.21% |
| 4 | Financials | 11.2% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Scotiabank
BNS
$113B
| $24.6M | 0.09% |
430,485
-76,400
| -15% | -$4.6M |
|
252
Check Point Software Technologies
CHKP
$14.2B
| $24.2M | 0.09% |
247,743
+14,332
| +6% | +$1.42M |
|
|
WBA
253
DELISTED
Walgreens Boots Alliance
WBA
| $23.6M | 0.09% |
392,505
+6,194
| +2% | +$399K |
|
254
Lear
LEA
$6.27B
| $22.9M | 0.09% |
123,102
-17,352
| -12% | -$3.4M |
|
255
Magna International
MGA
$16.9B
| $22.8M | 0.09% |
392,767
-128,766
| -25% | -$7.99M |
|
256
Cinemark Holdings
CNK
$3.98B
| $22.7M | 0.09% |
646,690
+24,200
| +4% | +$892K |
|
|
FISV
257
Fiserv Inc
FISV
$27.1B
| $22.7M | 0.09% |
305,768
-318
| -0.1% | -$23.1K |
|
258
Sysco
SYY
$38.6B
| $22.6M | 0.09% |
331,404
-375
| -0.1% | -$24K |
|
|
DRE
259
DELISTED
Duke Realty Corp.
DRE
| $22.6M | 0.09% |
778,815
-189,508
| -20% | -$5.23M |
|
260
Humana
HUM
$47.5B
| $22.4M | 0.09% |
75,189
+8,155
| +12% | +$2.39M |
|
261
Edwards Lifesciences
EW
$49.5B
| $22.3M | 0.09% |
460,293
+47,190
| +11% | +$2.2M |
|
262
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
| $21.8M | 0.08% |
410,511
+19,200
| +5% | +$1.02M |
|
263
Huntsman Corp
HUN
$1.63B
| $21.8M | 0.08% |
745,800
+60,700
| +9% | +$1.88M |
|
264
Snap-on
SNA
$19.5B
| $21.6M | 0.08% |
134,136
-2,339
| -2% | -$354K |
|
265
Zoetis
ZTS
$30.3B
| $21.3M | 0.08% |
249,493
-24,691
| -9% | -$2.08M |
|
|
STMP
266
DELISTED
Stamps.com, Inc.
STMP
| $21M | 0.08% |
82,828
+17,100
| +26% | +$4.12M |
|
|
SPLK
267
DELISTED
Splunk Inc
SPLK
| $20.8M | 0.08% |
210,193
+25,999
| +14% | +$2.83M |
|
268
ON Semiconductor
ON
$28.4B
| $20.6M | 0.08% |
928,488
+25,688
| +3% | +$621K |
|
269
PagSeguro Digital
PAGS
$2.72B
| $20.6M | 0.08% |
741,235
+540,235
| +269% | +$17.9M |
|
270
United Rentals
URI
$61.5B
| $20.6M | 0.08% |
139,237
-90,359
| -39% | -$14.8M |
|
271
Lam Research
LRCX
$334B
| $20.5M | 0.08% |
1,186,880
-1,462,020
| -55% | -$28.2M |
|
272
Franklin Templeton
BEN
$16.9B
| $20.4M | 0.08% |
637,636
+390,131
| +158% | +$13.1M |
|
273
Goldman Sachs
GS
$280B
| $20.4M | 0.08% |
92,283
-917
| -1% | -$219K |
|
274
Amdocs
DOX
$6.62B
| $20.3M | 0.08% |
307,300
+11,900
| +4% | +$801K |
|
275
Boston Properties
BXP
$10.2B
| $20.2M | 0.08% |
161,335
+257
| +0.2% | +$31.2K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2018 Portfolio in Review
As of Q2 2018, Axa held 1,470 positions worth $26.1B, up 4.1% from $25.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa's Q2 2018 filing shows 112 new, 493 increased, 531 reduced and 130 closed positions. Its largest new stake was Foot Locker: 289,100 shares worth $15.2M. The largest sale was AbbVie, an estimated $81.3M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Axa's largest Q2 2018 buy was Foot Locker: 289,100 shares worth $15.2M.
- Axa added most to TE Connectivity in Q2 2018, an estimated $94.2M increase.
- Axa's biggest Q2 2018 reduction was AbbVie, cutting an estimated $81.3M.
- Axa fully exited PG&E in Q2 2018, selling an estimated $52M.
- Axa's ten largest holdings make up 14% of its $26.1B portfolio in Q2 2018.
- Axa opened 112 new positions and closed 130 in Q2 2018.
- Axa's portfolio value rose 4.1% quarter-over-quarter to $26.1B.
Based on Axa's 13F filing for Q2 2018, filed 13 Aug 2018.